title: The scientific and clinical results of ex vivo activated T cells for metastatic renal cell carcinoma in over 500 human patients.
authors.affiliation: Department Urology, Boston University, MA 02215.
authors.forename: R J
authors.initials: RJ
authors.lastname: Krane
authors.forename: S D
authors.initials: SD
authors.lastname: Ross
authors.forename: B
authors.initials: B
authors.lastname: Babbitt
authors.forename: P T
authors.initials: PT
authors.lastname: Lavin
authors.forename: J
authors.initials: J
authors.lastname: Martin
authors.forename: J
authors.initials: J
authors.lastname: Goodwin
authors.forename: B
authors.initials: B
authors.lastname: Caplan
authors.forename: J
authors.initials: J
authors.lastname: Zhang
authors.forename: M E
authors.initials: ME
authors.lastname: Osband
mesh_terms: D015703:Antigens, CD / Q000032:analysis; D001804:Blood Transfusion, Autologous; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D008213:Lymphocyte Activation; D017710:Lymphocyte Transfusion; D009362:Neoplasm Metastasis; D016176:T-Lymphocyte Subsets / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D015703:Antigens, CD